---
title: "Calidi Biotherapeutics Falls Nearly 6% After Board Restructuring Announcement"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284409864.md"
description: "卡里迪生物治疗公司（CLDI.US）现价 $0.2238，当日 -5.77%，盘中股价持续承压。公司为专注肿瘤溶解病毒平台的临床阶段生物科技企业。近期公告显示，公司拟精简董事会结构并强化审计委员会监督职能，市场对该治理调整持观望态度，叠加小市值生物科技板块整体情绪偏弱，股价随之走低。目前暂无重大临床进展消息，短期走势仍受市场对公司运营前景不确定性所主导。"
datetime: "2026-04-28T14:43:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284409864.md)
  - [en](https://longbridge.com/en/news/284409864.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284409864.md)
generator: "portal-rs"
---

# Calidi Biotherapeutics Falls Nearly 6% After Board Restructuring Announcement

Calidi Biotherapeutics (CLDI.US) traded at $0.2238, down **-5.77%** on the day, with shares under sustained pressure throughout the session.

The company is a clinical-stage biotherapeutics firm focused on an oncolytic virus platform. Shares fell after the company announced plans to streamline its board composition and enhance audit committee oversight, a governance change that the market interpreted with caution. No major clinical milestones have been disclosed recently, and near-term price action is likely to remain driven by uncertainty surrounding the company's operational trajectory.

### Related Stocks

- [CLDI.US](https://longbridge.com/en/quote/CLDI.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)

## Related News & Research

- [Calidi Biotherapeutics Received NYSE American Notification Letter Regarding Stockholders’ Equity Deficiency | CLDI Stock News](https://longbridge.com/en/news/300165587.md)
- [Calidi Biotherapeutics Raises $1.2 Million in Registered Direct Offering at $1.17 Per Share](https://longbridge.com/en/news/299813801.md)
- [Oncopeptides earns EANO poster nod as PDC platform pushes into glioblastoma](https://longbridge.com/en/news/299726078.md)
- [Siloam says no undisclosed material information behind Sept. 18 share price volatility](https://longbridge.com/en/news/299881572.md)
- [Cathie Wood Loads Up On Biotech: 5 ETFs Holding Her Latest Bets](https://longbridge.com/en/news/299785900.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**